PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas
Abstract The self-renewal transcription factor Nanog and the phosphoinositide 3-kinase (PI3K)–Akt pathway are known to be essential for maintenance of mesenchymal stem cells. We evaluated their contribution to the maintenance of CD133(+) cancer stem-like cells (CSCs) and spheroid-forming cells in pa...
Main Authors: | Changhwan Yoon, Jun Lu, Brendan C. Yi, Kevin K. Chang, M. Celeste Simon, Sandra Ryeom, Sam S. Yoon |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-01-01
|
Series: | Oncogenesis |
Online Access: | https://doi.org/10.1038/s41389-020-00300-z |
Similar Items
-
PIK3R3, part of the regulatory domain of PI3K, is upregulated in sarcoma stem-like cells and promotes invasion, migration, and chemotherapy resistance
by: Changhwan Yoon, et al.
Published: (2021-07-01) -
PI3K/Akt Pathway Activation Attenuates the Cytotoxic Effect of Methyl Jasmonate Toward Sarcoma Cells
by: Uri Elia, et al.
Published: (2008-11-01) -
Mesenchymal stem cells targeting PI3K/AKT pathway in leukemic model
by: Esraa S A Ahmed, et al.
Published: (2019-04-01) -
The deubiquitinase USP21 maintains the stemness of mouse embryonic stem cells via stabilization of Nanog
by: Jiali Jin, et al.
Published: (2016-11-01) -
PI3K/AKT Pathway and Brain Malformations
by: Gavin B. Rice, et al.
Published: (2015-07-01)